Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Italy launches COVID inquiry over opposition protest

Published 14/02/2024, 18:54
© Reuters. FILE PHOTO: A sign warning people to stay at home is seen in the town of Casalpusterlengo amid a coronavirus outbreak in northern Italy, February 22, 2020. REUTERS/Flavio Lo Scalzo/File Photo

By Angelo Amante

ROME (Reuters) - Italy's parliament approved on Wednesday the creation of an official inquiry into the handling of the COVID-19 pandemic, angering opposition parties who were in power at the time and fear it will become a political witch hunt.

The lower house, now dominated by right-wing parties from Prime Minister Giorgia Meloni's ruling coalition, approved the bill to set up the inquiry by vote of 132 to 86.

The rightist groups were fierce critics of lockdowns and restrictions introduced by the centre-left administration of then Prime Minister Giuseppe Conte to stem infections as Italy became the first Western nation to face the health emergency in 2020.

"This law is a clown show put on by cowards, an unworthy act that tramples on the duties and functions of this house and of the entire parliament... for mere propaganda purposes," said Angela Raffa, a lawmaker with the opposition 5-Star Movement led by Conte.

The panel will include members from all political parties in both houses of parliament. To carry out its investigation, it will be allowed to acquire relevant documents and hold hearings.

Its tasks will include assessing the readiness and effectiveness of measures put in place before the virus struck, also with an eye to dealing with any future pandemic, according to the law bill seen by Reuters.

The World Health Organization says more than 195,000 people died of COVID-19 in Italy, the second highest toll in Europe after Britain, which is currently holding a public inquiry into its own, much-criticised handling of the pandemic.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Lawmakers from Meloni's coalition have argued that an array of topics need closer scrutiny from parliament, including why Italy had not updated a pandemic plan drawn up in 2006.

Choices made by Conte and his health minister Roberto Speranza will likely be the focus of the panel's investigation, whose results are expected to be presented by the end of the legislature in 2027.

A legal case against Conte and Speranza for allegedly mishandling the start of the crisis was dropped last year in the northern city of Bergamo, which was at the epicentre of the initial Italian outbreak.

"I have no fears about the investigation that will be carried out," Conte told the house after the vote to launch the inquiry.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.